iCAD develops artificial intelligence solutions for cancer detection, specifically focusing on breast cancer screening and assessment. The company provides AI-powered tools for detection, density assessment, and risk evaluation.

iCAD

Domain Not Resolving

HSTS

DNSSEC

Amazon

IPv6

IIS 10

HSTS IncludeSubdomains PreLoad

Microsoft

Amazon SSL

Microsoft Azure

Owner

Amy Osborne

Bill Powell

President & CEO

Dana Brown

George Lungu

Chief Commercial Officer

Jeffrey Sirek

Max Maksim_Usa

Chairman/CEO

Sali Usman

Co-Owner

Sheila Niczad

President and CEO

Stacey Stevens

Manager, Quality Assurance

Bob MacKeen

Rachel Brem

Anthony F. Ecock

Lawrence Howard

Elliot Sussman

Steven Rappaport

Susan A. Wood

Somu Subramaniam

Michael Klein

Ken Ferry

President & Chief Executive Officer, Board of Directors

Thomas Rusch

Co-founder

Charles Carter

Chief Financial Officer

Stephen P. Sarno

Interim Chief Financial Officer

Jonathan Go

Chief Technology Officer

Andy Sassine

Board of Director, Chairman of Audit Committee

Northeastern US Companies With More Than $1M in Revenue (Top 10K)

Northeastern US Health Care Companies (Top 10K)

Medical Device Public Companies With More Than $1M in Revenue

United States Public Companies With More Than $10M in Revenue

iCAD provides cancer detection and therapy solutions. Their breast health solutions provide software solutions for digital breast tomosynthesis and breast density. Breast cancer solutions also provide tools to support disease detection and analysis.

Post-IPO Equity - iCAD

Post-IPO Debt - iCAD

Nashua

New Hampshire

United States

North America

iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

NIBSS reminds banks, others to forward customers account details to ICAD

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference

iCAD reports Q1 EPS (5c), consensus (6c)

Earnings call: iCAD reports growth and strategic advancements in Q1 2024

Hedvig Hricak Named to iCAD's Board of Directors

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

Michael J. Doyle Joins iCAD Board of Directors

Institute for Career Advising & Development (ICAD)

India

Asia

Thailand

Romania

Europe

Panama

HTML5

Google Cloud Translation API

Wordpress

jQuery

Google Analytics

Wistia

Adobe Fonts

F5 NGINX

Apache Server

Google Maps API

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

iCAD, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 17, 2024 5:47 AM	a8f5a1e2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 17, 2024 5:47 AM	b36b7526
crunchbase trigger	general	Nov 18, 2024 2:12 PM	3d449385
crunchbase profile	general	Nov 18, 2024 3:51 PM	aa5a09d0
li profile	general
translate crunchbase fundingrounds	general	Nov 18, 2024 4:18 PM	a3c967dd
peers	general	Sep 17, 2024 5:47 AM	8395cc93
news basic	general	Sep 17, 2024 5:47 AM	2efea19c
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ICADMED

iCAD

Last Close

1.54

22/11 21:00

Market Cap

34.50M

Beta: -

Volume Today

171.23K

Avg: -